Taiwanese Pharmaceuticals & Biotech Price disconnect

TTY Biopharm

Market Cap: NT$18.9b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

Orient Pharma

Market Cap: NT$5.3b

Engages in the development of new drugs in Taiwan and internationally.

Cenra

Market Cap: NT$5.1b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.

Vetnostrum Animal Health

Market Cap: NT$2.3b

Engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.

Allied Biotech

Market Cap: NT$2.3b

Engages in the manufacture and sale of carotenoids worldwide.

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.8b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

Bioray Biotech

Market Cap: NT$505.9m

Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.